The Week -
3 Feb 2022 06:40
Doctors at the University of Pennsylvania say that 10 years after treating two leukemia patients with an experimental gene therapy, both men were still in remission. The doctors wrote about the cases in a study published Wednesday in the journal Nature. The treatment is called CAR-T cell therapy, and involves genetically changing T cells so they immediately attack cancer, The Associated Press reports. The cells remain in the body for years, and as they evolve, keep the cancer at bay. This was th...
Share this Article
Comment on this Article
Please to comment